Nav: Home

New method for engineering metabolic pathways

June 05, 2019

Cells are incredibly adept at creating complex molecules, like therapeutics, and can do so much better than many of our best factories.

Synthetic biologists look to re-engineer cells to make these molecules for specific needs, including pharmaceuticals and energy applications. But the trial-and-error process is difficult and time-consuming, and often competes with the cell's other goals and processes, like growth and survival.

A new method developed at Northwestern University combines two state-of-the-art research approaches to create a fast, efficient way to engineer and analyze metabolic pathways.

The approaches -- cell-free protein synthesis and self-assembled monolayer desorption ionization (SAMDI) mass spectrometry -- combine to make a new tool to help engineers better understand the pathways to create molecules.

"With these two methods, we can build thousands of potential mixtures and test them all in a single day, a much faster process that will give new insights and design rules for synthetic biologists," said Milan Mrksich, the Henry Wade Rogers Professor of Biomedical Engineering, Chemistry, and Cell and Molecular Biology at Northwestern's McCormick School of Engineering. He is also the co-director of Northwestern's Center for Synthetic Biology.

The results were published June 5 in the journal Science Advances. Michael Jewett, the Charles Deering McCormick Professor of Teaching Excellence, professor of chemical and biological engineering, and co-director of the Center for Synthetic Biology, is a co-corresponding author of the research.

Creating enzymes through cell-free synthesis

Cells develop complex molecules through enzymes, the protein that is used to convert one molecule to another. Through a series of these conversions, a metabolite becomes a complex molecule, one that often is associated with societal benefit.

For engineers to mimic this process, they need to identify which enzymes are required to give them the desired molecule. Once they understand that metabolic pathway, they can engineer a cell -- often a bacteria cell -- to make the enzymes to create the target molecule. For example, Coenzyme A (CoA) is a central molecule in metabolism, and synthetic biologists have used its dependent pathways to engineer antimalarial drugs, brewer's yeast, and advanced biofuels.

But finding these pathways is a trial-and-error process that can take days of effort to both engineer and then test the outcome. To get past this, Jewett's lab has developed a process of cell-free protein synthesis that creates just the enzymes needed to make the target product molecules, but without having to use the whole cell itself. Here, the lab created enzymes, which allows them to mix and match potential enzymes in reaction tubes without having their ultimate goals compete with a cell's other goals, like maintaining its metabolism.

"Cell-free protein synthesis is really an exciting technology," Jewett said. "The cocktail-based approach for constructing biosynthetic functions using cell-free systems we describe here is achieving an unprecedented freedom of design to expand the capabilities of natural biocatalysts."

Analyzing quickly with SAMDI

Once these solutions are created, testing their success requires at least a half hour per sample. Because there are so many possible solutions, that manual process is not efficient enough to search for the optimal outcomes.

That's where Mrksich's SAMDI mass spectrometry comes in. The technology measures biochemical reactions extremely quickly and cheaply. "We can easily test 10,000 reaction mixtures in a single day to determine which molecules were synthesized and how much of each is present in the reaction mixtures," Mrksich said.

Additionally, the method allows them to observe all the molecules present in the reaction, which means they can find molecules that they weren't necessarily searching for in the first place. "That's pretty exciting," Mrksich said. "It's a powerful scientific tool that teaches us about how these reactions are balanced and trade off each other in the cell."

Creating factories with cells

To prove this method, the researchers synthesized hydroxymethylglutaryl-CoA (HMG-CoA), a common metabolite used in the synthesis of many complex molecules, including a class of important molecules known as isoprenoids (including steroids and cancer drugs), and mapped more than 800 unique reaction conditions.

"Today, a typical synthetic biology project might explore dozens of variants of a pathway," Jewett said. "With our method, we show it's possible to test hundreds to thousands of pathway variations. This is important because it will enable new types of data driven design to facilitate pathway optimization."

Because the SAMDI method creates so many data points for each test, the researchers hope to employ more machine learning and artificial intelligence methods going forward to help them analyze and make sense of all the data.

The ultimate goal is to have enough of an understanding to harness the power of a cell to create next-generation pharmaceuticals and sustainable chemicals for energy. Just as rapid increases in the performance of computational devices -- described by Moore's law -- has had a profound impact on the entire computation and consumer electronics industry, "this approach represents the next step in engineering that will have an analogous impact on synthetic biology for all of its applications," Jewett said.

"Imagine replacing entire factories with a barrel of bacteria," Mrksich said. "Those bacteria cells can be engineered to produce our target molecules, without the high temperatures and unsafe solvents and chemicals that are normally required.. It's an attractive route to manufacturing chemicals, and with this new process, we've significantly improved the efficiency with which the pathways can be discovered and optimized."
-end-


Northwestern University

Related Synthetic Biology Articles:

Cell-free synthetic biology comes of age
In a review paper published in Nature Reviews Genetics, Professor Michael Jewett explores how cell-free gene expression stands to help the field of synthetic biology dramatically impact society, from the environment to medicine to education.
Scientists develop electrochemical platform for cell-free synthetic biology
Scientists at the University of Toronto (U of T) and Arizona State University (ASU) have developed the first direct gene circuit to electrode interface by combining cell-free synthetic biology with state-of-the-art nanostructured electrodes.
Gene-OFF switches tool up synthetic biology
Wyss researchers and their colloaborators have developed two types of programmable repressor elements that can switch off the production of an output protein in synthetic biology circuits by up to 300-fold in response to almost any triggering nucleotide sequence.
Tennessee researchers join call for responsible development of synthetic biology
Engineering biology is transforming technology and science. Researchers in the international Genome Project-write, including two authors from the UTIA Center for Agricultural Synthetic Biology, outline the technological advances needed to secure a safe, responsible future in the Oct.
Scientists chart course toward a new world of synthetic biology
A UC Berkeley team with NSF funding has compiled a roadmap for the future of synthetic or engineering biology, based on the input of 80 leaders in the field from more than 30 institutions.
DFG presents position paper on synthetic biology
Clear distinction between synthetic biology and underlying methods required / No new potential risks associated with current research work
Commandeering microbes pave way for synthetic biology in military environments
A team of scientists from the US Army Research Laboratory and the Massachusetts Institute of Technology have developed and demonstrated a pioneering synthetic biology tool to deliver DNA programming into a broad range of bacteria.
BioBits: Teaching synthetic biology to K-12 students
As biologists have probed deeper into the genetic underpinnings of life, K-12 schools have struggled to provide a curriculum that reflects those advances.
Sensor strategy a boon for synthetic biology
Rice University synthetic biologists have invented a technology to dial up or down the sensitivity of bacterial biosensors.
Drug-producing bacteria possible with synthetic biology breakthrough
Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles, from the University of Warwick and the University of Surrey.
More Synthetic Biology News and Synthetic Biology Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Our Relationship With Water
We need water to live. But with rising seas and so many lacking clean water – water is in crisis and so are we. This hour, TED speakers explore ideas around restoring our relationship with water. Guests on the show include legal scholar Kelsey Leonard, artist LaToya Ruby Frazier, and community organizer Colette Pichon Battle.
Now Playing: Science for the People

#569 Facing Fear
What do you fear? I mean really fear? Well, ok, maybe right now that's tough. We're living in a new age and definition of fear. But what do we do about it? Eva Holland has faced her fears, including trauma and phobia. She lived to tell the tale and write a book: "Nerve: Adventures in the Science of Fear".
Now Playing: Radiolab

Uncounted
First things first: our very own Latif Nasser has an exciting new show on Netflix. He talks to Jad about the hidden forces of the world that connect us all. Then, with an eye on the upcoming election, we take a look back: at two pieces from More Perfect Season 3 about Constitutional amendments that determine who gets to vote. Former Radiolab producer Julia Longoria takes us to Washington, D.C. The capital is at the heart of our democracy, but it's not a state, and it wasn't until the 23rd Amendment that its people got the right to vote for president. But that still left DC without full representation in Congress; D.C. sends a "non-voting delegate" to the House. Julia profiles that delegate, Congresswoman Eleanor Holmes Norton, and her unique approach to fighting for power in a virtually powerless role. Second, Radiolab producer Sarah Qari looks at a current fight to lower the US voting age to 16 that harkens back to the fight for the 26th Amendment in the 1960s. Eighteen-year-olds at the time argued that if they were old enough to be drafted to fight in the War, they were old enough to have a voice in our democracy. But what about today, when even younger Americans are finding themselves at the center of national political debates? Does it mean we should lower the voting age even further? This episode was reported and produced by Julia Longoria and Sarah Qari. Check out Latif Nasser's new Netflix show Connected here. Support Radiolab today at Radiolab.org/donate.